The Effect of a Sleep Education and Hypnotics Reduction Program on Hypnotics Prescription Rate for the Hospitalized Patients with Cancer at a General Hospital
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objective: We aimed to investigate whether the sleep education and hypnotics reduction program (the i-sleep program), developed for all hospitalized patients and medical personnel, help reducing the hypnotics prescriptions rate among hospitalized cancer patients in a general hospital. Methods: Patient data such as hypnotics prescribed at the time of admission and discharge during prior to (year of 2014) and after (year of 2015) initiation of the i-sleep program were collected and compared. Also, hypnotics prescription rate at the first day of each month of 2014 and 2015 were estimated and compared. Results: All of 12,382 patients in 2014 and 12,313 patients in 2015 were admitted to the Department of Oncology of the hospital. In 2014, 782 (6.3%) of 12,382 inpatients were already taking hypnotics at the time of admission, and 594 (76.0%) of the 782 patients were still taking sleeping pills at the time of discharge. Following initiation of the i-sleep program (2015), 792 (6.4%) of 12,313 inpatients were already taking hypnotics at the time of admission, and 553 (69.8%) of the 792 inpatients were still taking them at the time of discharge (relative risk, 0.92; 95% confidence interval, 0.87−0.98). On the first day of each month of 2014, 7.3% to 12.6% (mean, 10.0%) of inpatients had prescriptions for hypnotics. Following initiation of the program, the rate of hypnotic prescription was significantly reduced (3.2−10.8%; mean, 8.0%; p = 0.03). Conclusion: Our date showed that the i-sleep program may help to reduce the hypnotic prescription rate in hospitalized cancer patients.
Abstract
Objective: We aimed to investigate whether the sleep education and hypnotics reduction program (the i-sleep program), developed for all hospitalized patients and medical personnel, help reducing the hypnotics prescriptions rate among hospitalized cancer patients in a general hospital. Methods: Patient data such as hypnotics prescribed at the time of admission and discharge during prior to (year of 2014) and after (year of 2015) initiation of the i-sleep program were collected and compared. Also, hypnotics prescription rate at the first day of each month of 2014 and 2015 were estimated and compared. Results: All of 12,382 patients in 2014 and 12,313 patients in 2015 were admitted to the Department of Oncology of the hospital. In 2014, 782 (6.3%) of 12,382 inpatients were already taking hypnotics at the time of admission, and 594 (76.0%) of the 782 patients were still taking sleeping pills at the time of discharge. Following initiation of the i-sleep program (2015), 792 (6.4%) of 12,313 inpatients were already taking hypnotics at the time of admission, and 553 (69.8%) of the 792 inpatients were still taking them at the time of discharge (relative risk, 0.92; 95% confidence interval, 0.87−0.98). On the first day of each month of 2014, 7.3% to 12.6% (mean, 10.0%) of inpatients had prescriptions for hypnotics. Following initiation of the program, the rate of hypnotic prescription was significantly reduced (3.2−10.8%; mean, 8.0%; p = 0.03). Conclusion: Our date showed that the i-sleep program may help to reduce the hypnotic prescription rate in hospitalized cancer patients.
참고문헌 (20)
- Shapiro CM, "ABC of sleep disorders. Sleep problems in patients with medical illness", BMJ, 306, pp.1532~1535 (1993)
- Meyer TJ, "Adverse environmental conditions in the respiratory and medical ICU settings", Chest, 105, pp.1211~1216 (1994)
- Konkani A, "Noise in hospital intensive care units--a critical review of a critical topic", J Crit Care, 27, pp.522.e1~522.e9 (2012)
- Young JS, "Sleep in hospitalized medical patients, part 1 : factors affecting sleep", J Hosp Med, 3, pp.473~482 (2008)
- Ohayon MM, "Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom", J Clin Psychiatry, 63, pp.817~825 (2002)
- Bertisch SM, "National use of prescription medications for insomnia : NHANES 1999-2010", Sleep, 37, pp.343~349 (2014)
- Park B, "Prevalence of insomnia among patients with the ten most common cancers in South Korea : Health Insurance Review and Assessment Service-national patient sample", Sleep Med Res, 7, pp.48~54 (2016)
- Youn S, "Development of sleep-hygiene education and sleeping pills reduction program for hospitalized patients", Korean J Sleep Med, 17, pp.33~42 (2015)
- Seockhoon Chung, "A Sleep Education and Hypnotics Reduction Program for Hospitalized Patients at a General Hospital", PSYCHIATRY INVESTIGATION, 15(1), pp.78~83 (2018), 대한신경정신의학회[DOI]
- "Sleep know-how for hospitalized patients" (2014)[URL]
- McDowell JA, "A nonpharmacologic sleep protocol for hospitalized older patients", J Am Geriatr Soc, 46, pp.700~705 (1998)
- Youn S, "Preliminary results of sleep pill reduction program for psychiatric inpatients", Korean J Sleep Med, 12, pp.19~22 (2010)
- Lareau R, "Examining the feasibility of implementing specific nursing interventions to promote sleep in hospitalized elderly patients", Geriatr Nurs, 29, pp.197~206 (2008)
- Gooneratne NS, "Sleep and quality of life in long-term lung cancer survivors", Lung Cancer, 58, pp.403~410 (2007)
- Palesh O, "Actigraphy-measured sleep disruption as a predictor of survival among women with advanced breast cancer", Sleep, 37, pp.837~842 (2014)
- Spielman AJ, "A behavioral perspective on insomnia treatment", Psychiatr Clin North Am, 10, pp.541~553 (1987)
- Cella D, "Cancer-related fatigue : prevalence of proposed diagnostic criteria in a United States sample of cancer survivors", J Clin Oncol, 19, pp.3385~3391 (2001)
- Savard J, "Insomnia in the context of cancer : a review of a neglected problem", J Clin Oncol, 19, pp.895~908 (2001)
- Zhou ES, "Adapting cognitive-behavior therapy for insomnia in cancer patients", Sleep Med Res, 8, pp.51~61 (2017)
- 박영민, "Zolpidem Induced Sleep-related Eating and Complex Behaviors in a Patient with Obstructive Sleep Apnea and Restless Legs Syndrome", Clinical Psychopharmacology and Neuroscience, 14(3), pp.299~301 (2016), 대한정신약물학회